Plain-English translation of NCT06562166 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new approach to radiation therapy called online adaptive radiotherapy (or adaptive RT) for people being treated for cervical cancer. Unlike standard radiation therapy that uses the same treatment plan every day, adaptive RT uses imaging to see how your tumor and body have changed and adjusts the radiation dose right before each treatment. The study will compare this new approach with standard image-guided radiation therapy to see if it reduces side effects and improves how well the cancer is controlled.
During radiation treatment for cervical cancer, your body and tumor can shift and change day to day, which means the radiation dose may not always hit exactly where it needs to go. This trial exists to see if adjusting the treatment plan in real-time can deliver radiation more precisely, potentially causing less harm to healthy tissue and working better to treat the cancer.
You likely qualify if…
You likely don't qualify if…
You would receive radiation therapy combined with chemotherapy (platinum-based chemotherapy given once a week). Before each radiation treatment, you would have imaging scans to see where your tumor is that day, and the doctors would adjust your treatment plan if needed based on what they see. You would continue this combination treatment for at least 5 weeks, then return for regular follow-up appointments to monitor your progress and any side effects.
AI-generated summary from trial data · Jul 6, 2026 · Not medical advice
China
Phase
Testing effectiveness
Sponsor
Peking Union Medical College Hospital
Collaborators
Affiliated Hospital of Jiangsu University, Zhongnan Hospital
Enrollment target
~124 participants
Started
September 2024
Primary completion
August 2027
Age range
18 Years – 80 Years
Sex
Female only
Last updated on clinicaltrials.gov in January 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Shuai Sun
Peking Union Medical College Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.